Decazes P - Search Results

1

High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma.

Camus V, Viailly PJ, Drieux F, Veresezan EL, Sesques P, Haioun C, Durot E, Patey M, Rossi C, Martin L, Rainville V, Bohers E, Ruminy P, Penther D, Kaltenbach S, Bruneau J, Paillassa J, Tournilhac O, Willaume A, Antier C, Lazarovici J, Lévêque E, Decazes P, Becker S, Tonnelet D, Berriolo-Riedinger A, Gaulard P, Tilly H, Molina TJ, Traverse-Glehen A, Jardin F. Camus V, et al. Among authors: decazes p. Blood Adv. 2023 Dec 12;7(23):7331-7345. doi: 10.1182/bloodadvances.2023011169. Blood Adv. 2023. PMID: 37862676 Free PMC article.

2

Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.

Decazes P, Becker S, Toledano MN, Vera P, Desbordes P, Jardin F, Tilly H, Gardin I. Decazes P, et al. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1672-1679. doi: 10.1007/s00259-018-4041-0. Epub 2018 Apr 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 29705879

3

Correction to: Tumor fragmentation estimated by volume surface ratio of tumors measured on ¹⁸F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.

Decazes P, Becker S, Toledano MN, Vera P, Desbordes P, Jardin F, Tilly H, Gardin I. Decazes P, et al. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1838-1839. doi: 10.1007/s00259-018-4053-9. Eur J Nucl Med Mol Imaging. 2018. PMID: 29802427

4

Anthropometer3D: Automatic Multi-Slice Segmentation Software for the Measurement of Anthropometric Parameters from CT of PET/CT.

Decazes P, Tonnelet D, Vera P, Gardin I. Decazes P, et al. J Digit Imaging. 2019 Apr;32(2):241-250. doi: 10.1007/s10278-019-00178-3. J Digit Imaging. 2019. PMID: 30756268 Free PMC article.

5

Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab.

Popinat G, Cousse S, Goldfarb L, Becker S, Gardin I, Salaün M, Thureau S, Vera P, Guisier F, Decazes P. Popinat G, et al. Among authors: decazes p. Oncoimmunology. 2019 Mar 6;8(5):e1580128. doi: 10.1080/2162402X.2019.1580128. eCollection 2019. Oncoimmunology. 2019. PMID: 31069139 Free PMC article.

6

Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study.

Camus V, Viennot M, Lequesne J, Viailly PJ, Bohers E, Bessi L, Marcq B, Etancelin P, Dubois S, Picquenot JM, Veresezan EL, Cornic M, Burel L, Loret J, Becker S, Decazes P, Lenain P, Lepretre S, Lemasle E, Lanic H, Ménard AL, Contentin N, Tilly H, Stamatoullas A, Jardin F. Camus V, et al. Among authors: decazes p. Haematologica. 2021 Jan 1;106(1):154-162. doi: 10.3324/haematol.2019.237719. Haematologica. 2021. PMID: 32079702 Free PMC article.

7

Correlations between baseline ¹⁸F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma.

Decazes P, Camus V, Bohers E, Viailly PJ, Tilly H, Ruminy P, Viennot M, Hapdey S, Gardin I, Becker S, Vera P, Jardin F. Decazes P, et al. EJNMMI Res. 2020 Oct 7;10(1):120. doi: 10.1186/s13550-020-00717-y. EJNMMI Res. 2020. PMID: 33029662 Free PMC article.

8

Evaluation of an Automatic Classification Algorithm Using Convolutional Neural Networks in Oncological Positron Emission Tomography.

Pinochet P, Eude F, Becker S, Shah V, Sibille L, Toledano MN, Modzelewski R, Vera P, Decazes P. Pinochet P, et al. Among authors: decazes p. Front Med (Lausanne). 2021 Feb 26;8:628179. doi: 10.3389/fmed.2021.628179. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33718406 Free PMC article.

9

Angiogenesis imaging study using interim [¹⁸F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence.

Tonnelet D, Bohn MDP, Becker S, Decazes P, Camus V, Thureau S, Tilly H, Jardin F, Vera P. Tonnelet D, et al. Among authors: decazes p. EJNMMI Res. 2021 Apr 12;11(1):37. doi: 10.1186/s13550-021-00776-9. EJNMMI Res. 2021. PMID: 33846870 Free PMC article.

10

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study.

Camus V, Rossi C, Sesques P, Lequesne J, Tonnelet D, Haioun C, Durot E, Willaume A, Gauthier M, Moles-Moreau MP, Antier C, Lazarovici J, Monjanel H, Bernard S, Tardy M, Besson C, Lebras L, Choquet S, Le Du K, Bonnet C, Bailly S, Damaj G, Laribi K, Maisonneuve H, Houot R, Chauchet A, Jardin F, Traverse-Glehen A, Decazes P, Becker S, Berriolo-Riedinger A, Tilly H. Camus V, et al. Among authors: decazes p. Blood Adv. 2021 Oct 12;5(19):3862-3872. doi: 10.1182/bloodadvances.2021004778. Blood Adv. 2021. PMID: 34461634 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page